← SEC 公告列表 | INMD SEC 公告 | InMode(INMD)

重大事件 外國發行人報告 6-K 2026-07-10

InMode 確認收到非邀約收購提案,董事會成立特別委員會審議

於 SEC 網站開啟原文

AI 繁中摘要

InMode 確認收到非邀約收購提案 📄 申報類型:6-K(外國發行人報告) 申報日期:2026年7月10日 InMode(Nasdaq: INMD)發佈公告,確認其董事會已收到來自 Steel Partners Holdings L.P. 於2026年7月9日發出的非邀約收購提案。董事會已成立由全體獨立董事組成的特別委員會,將聯同法律及財務顧問,依照受信責任仔細審議該提案。 特別委員會強調將以全體股東最佳利益為依歸,現階段不會進一步評論。 InMode 總部位於以色列 Yokneam,為全球領先的醫療技術供應商,專注開發、製造及銷售基於射頻(RF)技術的微創手術設備,應用範疇涵蓋整形外科、婦科、皮膚科、耳鼻喉科及眼科。 此公告屬 6-K 申報,旨在向美國證監會(SEC)披露重大非財務事件。投資者應注意,提案尚在初步階段,不保證最終會達成任何交易。公司管理層未提供財務預測或業績展望,但提醒市場存在不確定性,包括提案可能被撤回、修改或出現競爭性要約等風險。 對投資者的潛在影響: - 提案可能引發股價波動,市場將密切關注特別委員會的最終決定。 - 若交易落實,可能為股東帶來溢價收購機會;但若談判失敗或出現更高報價,股價或受壓。 - 公司目前未提供任何時間表或條款細節,建議投資者審慎評估風險,並留意後續 8-K 或 6-K 更新。
展開英文正文
EX-99.1
2
exhibit_99-1.htm
EXHIBIT 99.1

 

 

Exhibit 99.1

 

InMode Confirms
Receipt of Unsolicited Proposal 

 

YOKNEAM, Israel – July 10, 2026 – InMode Ltd. (Nasdaq:
INMD) (the “Company”) confirmed that its Board of Directors (the “Board”) has received the unsolicited letter
and acquisition proposal from Steel Partners Holdings L.P. dated July 9, 2026.

 

The Special Committee comprised solely of the independent directors
of the Board (the “Special Committee”), together with its legal and financial advisors, will carefully review the proposal
consistent with its fiduciary duties.

 

The Special Committee remains committed to acting in the best interests
of all shareholders. The Special Committee does not intend to comment further at this time.

 

About InMode Ltd.

 

The Company is a leading global provider of innovative medical technologies.
The Company develops, manufactures and markets devices harnessing novel radiofrequency (“RF”) technology. The Company strives
to enable new emerging surgical procedures as well as improve existing treatments. The Company has leveraged its medically accepted minimally
invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology,
otolaryngology and ophthalmology. For more information about the Company and its wide array of medical technologies, visit www.inmodemd.com.

 

Forward-Looking Statements

 

This press release contains “forward-looking statements”
within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are
not historical facts. In some cases, forward-looking statements can be identified by terms such as “anticipate,” “believe,”
“could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,”
“predict,” “project,” “should,” “will,” “would” or the negative of those terms
or other comparable terminology. Forward-looking statements in this press release include, but are not limited to, statements regarding
the Proposal, the special committee’s review and evaluation of the Proposal, the potential consummation of any transaction and the
Company’s future plans, objectives, expectations and intentions. These statements involve known and unknown risks, uncertainties,
and other factors that may cause the Company’s actual results, performance or achievements to be materially different from those
expressed or implied. Such factors include, among others: uncertainties as to whether the special committee will determine that the Proposal
or any alternative transaction is in the best interests of the Company and its shareholders; the risk that the Proposal may be withdrawn
or modified; the possibility that competing offers or alternatives may or may not emerge; the risk that any transaction may not be consummated
on the terms or timeline currently contemplated, or at all; and the other risks described in the Company’s filings with the U.S.
Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement, whether as a result
of new information, future events or otherwise except as required by law.

 

Contacts

 

Miri Segal-Scharia

MS-IR LLC

[email protected]